Hong Kong-based startup Great Bay Bio secures $15M funding – BSA bureau

// Its two proprietary AI+CMC (chemistry, manufacturing, and controls) technology platforms, AlfaCell and AlfaMedX, have been successfully commercialized and used by multiple biopharma companies. https://www.biospectrumasia.com/news/48/21040/hong-kong-based-startup-great-bay-bio-secures-15m-funding.html //